விடியல் மர்கல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from விடியல் மர்கல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In விடியல் மர்கல் Today - Breaking & Trending Today

Two-drug combo starves bone cancer cells to death


Starving cancer cells of the energy they need to grow could one day provide an alternative to a commonly used chemotherapy drug without the risk of severe side effects, according to a new study.
Studying human cancer cells and mice, researchers report that a two-drug combination targeting a tumor’s energy sources could prove as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer.
Osteosarcoma is the most common tumor of the bone in adults and children. It accounts for about 4% of all pediatric cancers and more than half of all pediatric bone cancers. Standard treatment for osteosarcoma includes surgery, radiation, and a cocktail of chemotherapy drugs including high-dose methotrexate, which can cause liver and kidney damage. ....

United States , Richa Rathore , Sarcoma Foundation Of America , Siteman Cancer Center At Barnes , Washington University Surgical Oncology Training Grant , National Institutes Of Health , Washington University School Of Medicine , Washington University In St , Kellsie Hope Foundation , Brian Van Tine , Washington University , Van Tine , Young Adult Sarcoma , Siteman Cancer Center , Barnes Jewish Hospital , Siteman Kids , Louis Children , Washington University School , Dawn Merkel , Bone Chili Cook Off , Hope Foundation , Sarcoma Foundation , National Institutes , ஒன்றுபட்டது மாநிலங்களில் , ரிச்சா ரதோரே , சர்கோமா அடித்தளம் ஆஃப் அமெரிக்கா ,

Nixing bone cancer fuel supply offers new treatment approach, mouse study suggests | The Source


Two drugs targeting cancer cells’ energy source potentially could replace toxic chemo in osteosarcoma
January 26, 2021
SHARE
A new study from Washington University School of Medicine in St. Louis suggests that a two-drug combination targeting a tumor’s energy sources could be as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer. Shown is a cross section of osteosarcoma. (Image: Richa Rathore)
An innovative approach to treating bone tumors starving cancer cells of the energy they need to grow could one day provide an alternative to a commonly used chemotherapy drug without the risk of severe side effects, suggests a new study from Washington University School of Medicine in St. Louis. Studying human cancer cells and mice, the researchers said that a two-drug combination targeting a tumor’s energy sources could be as effective and less toxic than methotrexate, a l ....

United States , Luminex Flexmap , Laura Shelton , Richa Rathore , School Of Medicine , Sarcoma Foundation Of America , Siteman Cancer Center At Barnes , National Cancer Institute , National Institutes Of Health , Washington University School Of Medicine , Siteman Cancer Center , Kellsie Hope Foundation , Washington University Diabetes Research Center , Immunomonitoring Laboratory , Washington University Surgical Oncology Training Grant , Cancer Center Support Grant , Washington University School , Brian Van Tine , Van Tine , Young Adult , Barnes Jewish Hospital , Siteman Kids , Louis Children , Dawn Merkel , Bone Chili Cook Off , Hope Foundation ,

Nixing bone cancer fuel supply offers new treatment approach, mouse study suggests


 E-Mail
IMAGE: A new study from Washington University School of Medicine in St. Louis suggests that a two-drug combination targeting a tumor s energy sources could be as effective and less toxic than.
view more 
Credit: RICHA RATHORE
An innovative approach to treating bone tumors - starving cancer cells of the energy they need to grow - could one day provide an alternative to a commonly used chemotherapy drug without the risk of severe side effects, suggests a new study from Washington University School of Medicine in St. Louis. Studying human cancer cells and mice, the researchers said that a two-drug combination targeting a tumor s energy sources could be as effective and less toxic than methotrexate, a long-used chemotherapy drug often given in high doses to treat osteosarcoma, a bone cancer. ....

United States , Luminex Flexmap , Laura Shelton , Richa Rathore , School Of Medicine , Sarcoma Foundation Of America , Siteman Cancer Center At Barnes , National Cancer Institute , National Institutes Of Health , Washington University School Of Medicine , Siteman Cancer Center , Kellsie Hope Foundation , Washington University Diabetes Research Center , Immunomonitoring Laboratory , Washington University Surgical Oncology Training Grant , Cancer Center Support Grant , Washington University School , Brian Van Tine , Van Tine , Young Adult Sarcoma , Barnes Jewish Hospital , Siteman Kids , Louis Children , Dawn Merkel , Bone Chili Cook Off , Hope Foundation ,